Vertex Pharmaceuticals Inc Share Price
NASDAQ: VRTXHealthcare
Live Vertex Pharmaceuticals Inc Share Price Chart
O H L
Vertex Pharmaceuticals Inc Performance Overview
Days Range
▼
$510.30Low
$518.96High
Markets Today
| Previous Close | $513.26 |
|---|---|
| Open | $518.96 |
| Volume | 172,871 |
| Day's Range | $510.30 - $518.96 |
| 52W Range | $374.17 - $560.25 |
| Market Cap | $130.44 B |
Historical Performance
| 1M Returns | -0.44 |
|---|---|
| 3M Returns | +11.82 |
| 6M Returns | +10.98 |
| 1Y Returns | +32.57 |
| 5Y Returns | +172.58 |
| 10Y Returns | +462.42 |
Vertex Pharmaceuticals Inc Fundamentals
| Market Cap | $130.44 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 29.94 |
| PEG Ratio | N/A |
| Revenue | $12.00 B |
| ROE TTM | 0.23 |
| EPS TTM | $17.19 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 6.44 |
| EBITDA | $4.90 B |
| Profit Margin | 32.94 |
| Market Cap | $130.44 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 29.94 |
| PEG Ratio | N/A |
| Revenue | $12.00 B |
| ROE TTM | 0.23 |
| EPS TTM | $17.19 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 6.44 |
| EBITDA | $4.90 B |
| Profit Margin | 32.94 |
Vertex Pharmaceuticals Inc Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $2.77 B | $2.96 B | $3.08 B | $3.19 B | $2.99 B | $3.33 B |
| Gross Profit + | $2.41 B | $2.56 B | $2.66 B | $2.72 B | $2.59 B | $2.84 B |
| Operating Income | $630.10 M | $1.15 B | $1.19 B | $1.21 B | $1.14 B | $1.25 B |
| EBITDA | $1.08 B | $1.21 B | $1.29 B | $1.32 B | $1.19 B | $1.32 B |
| Interest Expense | $0 | $0 | -$3.30 M | -$3.30 M | $0 | $0 |
| Depreciation | $449.40 M | $53.90 M | $108.50 M | $112.20 M | $56.60 M | $77.90 M |
| Income Before Tax | $730.40 M | $1.28 B | $1.30 B | $1.33 B | $1.25 B | $1.39 B |
| Income Tax Expense | $84.10 M | $250.10 M | $215.90 M | $139.90 M | $221.50 M | $292.00 M |
| Net Income + | $646.30 M | $1.03 B | $1.08 B | $1.19 B | $1.03 B | $1.10 B |
| Net Profit Margin | 23.33% | 34.84% | 35.2% | 37.34% | 34.53% | 32.99% |
Vertex Pharmaceuticals Inc Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $2.60 M | $2.60 M | $2.50 M | $2.50 M | $2.50 M | $2.50 M |
| Reserve & Surplus | $10.32 B | $11.18 B | $12.30 B | $13.54 B | $14.62 B | $15.74 B |
| Non-Current Liabilities | $2.60 B | $2.72 B | $3.07 B | $3.12 B | $3.24 B | $3.24 B |
| Current Liabilities | $3.78 B | $4.14 B | $4.48 B | $3.86 B | $3.88 B | $3.94 B |
| Total Liabilities | $6.38 B | $6.86 B | $7.54 B | $6.98 B | $7.12 B | $7.18 B |
| Fixed Assets | $1.74 B | $1.77 B | $1.85 B | $1.94 B | $2.03 B | $2.08 B |
| Current Assets | $10.01 B | $10.43 B | $10.57 B | $11.20 B | $11.73 B | $12.54 B |
| Total Assets | $22.88 B | $24.04 B | $24.86 B | $25.64 B | $26.48 B | $27.42 B |
Vertex Pharmaceuticals Inc Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $646.30 M | $1.03 B | $1.08 B | $1.19 B | $1.03 B | $1.10 B |
| Operating Cash Flow | $818.90 M | $1.07 B | $1.24 B | $498.00 M | $1.43 B | $1.13 B |
| Investing Cash Flow | -$55.80 M | -$484.50 M | -$117.00 M | -$288.10 M | -$431.90 M | -$45.80 M |
| Financing Cash Flow | -$680.40 M | -$349.20 M | -$1.15 B | -$77.20 M | -$538.80 M | -$426.70 M |
| Change in Cash | $113.20 M | $296.60 M | -$34.20 M | $140.00 M | $417.10 M | $649.20 M |
Vertex Pharmaceuticals Inc Peer Comparison
| Company | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|
 | $5.01B | -58.07% | 0.00 | -16569.77% | 0.00% |
 | $57.40B | -66.14% | 0.00 | -145.16% | 0.00% |
 | $1.01T | 394.49% | 38.13 | 31.67% | 0.61% |
 | $464.82B | 143.67% | 74.40 | 6.92% | 2.63% |
 | $4.18T | 139.89% | 17.16 | 32.81% | 0.26% |
 | $10.69B | 613.22% | 0.00 | -28.69% | 0.00% |
 | $2.68T | 42.07% | 19.98 | 10.83% | 0.00% |
 | $157.03B | -37.43% | 36.44 | 12.48% | 6.24% |
 | $133.24B | 10.57% | 43.22 | 28.58% | 0.00% |
 | $403.92M | -95.71% | 0.00 | -395.01% | 0.00% |
Vertex Pharmaceuticals Inc Return Calculator
The Vertex Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$27,245
Invested Amount$10,000
Est. Returns$17,245
About Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Popular Stocks
FAQs
What is the share price of Vertex Pharmaceuticals Inc today?
Vertex Pharmaceuticals Inc (VRTX) share price as of September 17, 2026 is $513.03. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Vertex Pharmaceuticals Inc?
Yes, Indian Investors can invest in the Vertex Pharmaceuticals Inc (VRTX) Share by opening an international trading account with Angel One.
How can I purchase Vertex Pharmaceuticals Inc shares in India?
Purchasing Vertex Pharmaceuticals Inc (VRTX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Vertex Pharmaceuticals Inc (VRTX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Vertex Pharmaceuticals Inc?
Yes, you can purchase fractional shares of Vertex Pharmaceuticals Inc (VRTX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Vertex Pharmaceuticals Inc?
The market capitalization of Vertex Pharmaceuticals Inc on September 17, 2026, is $130.44 B.
In which sector Vertex Pharmaceuticals Inc belongs?
Vertex Pharmaceuticals Inc operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Vertex Pharmaceuticals Inc stocks?
In order to invest in Vertex Pharmaceuticals Inc (VRTX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
